IL17A and liver dysplastic nodule: A protective effect by treatment with a neutralizing IL-17A monoclonal antibody, and accordingly, the renal lesions were diminished in IL-17A deficient mice compared to wild-type mice [63], suggesting that IL-17A could promote DN.